Introduction 

What is Tolosa-Hunt Syndrome, and what are its effects on your cranial nerves and eye function? 

Tolosa-Hunt Syndrome (THS), also known as painful/recurrent ophthalmoplegia (paralysis or weakness of the eye muscles), is a rare, complex neurological condition caused by inflammation of the cavernous sinus or superior orbital fissure. THS is a type of painful cranial nerve condition that affects cranial nerves (CN) III, IV, and VI, which impairs motor function that is crucial for eye movement and control of certain facial muscles.

Individuals with THS often experience symptoms such as sudden, severe headaches, double vision, ptosis (drooping eyelids) and painful and/or restricted eye movements. These symptoms may occur and resolve spontaneously, which makes THS a debilitating condition for people to live with. 

Due to its debilitating nature, understanding the sophisticated interactions between the cranial nerves and inflammatory processes in THS is imperative to assist healthcare professionals in accurately diagnosing, implementing targeted interventions and effectively managing symptoms to improve the overall quality of life for individuals with this condition.^1,2 

Anatomy of cranial nerves III, IV, and VI 

The anatomy and basic functions of the three oculomotor cranial nerves are as follows: 

Cranial nerve III (oculomotor)

Cranial nerve III (CN III), also known as the oculomotor nerve, is the major cranial nerve that controls most eye movements. CN III originates from the midbrain, specifically from the oculomotor and accessory parasympathetic nucleus. CN III controls upper eyelid elevation and enables smooth visual tracking and gaze fixation due to CN III supplying nerves to four of the six eye muscles (the superior rectus, medial rectus, inferior rectus, and inferior oblique). CN III also regulates pupil constriction (miosis) whilst altering lens curvature (accommodation) via the ciliary muscle (which controls the shape of the lens of the eye), through the cavernous sinus and supraorbital fissure and branching to the orbit of the eye.³

Cranial nerve IV (trochlear)

Cranial nerve IV (CN IV), also known as the trochlear nerve, controls the downward, inward and outward eye movements of the eye. Despite being the smallest cranial nerve, CN IV originates from the trochlear nucleus in the midbrain, and has the longest intracranial course through the skull, extending sideways and in front of the pons, through the cavernous sinus and superior orbital fissure to the superior oblique muscle at the orbit of the eye. CN IV is vulnerable to injury; symptoms of damage include vertical double vision and blurry vision when looking downward and inward.⁴ 

Cranial nerve VI (abducens)

Cranial nerve VI (CN VI), also known as the abducens nerve, controls the lateral rectus muscle for outward eye movement (abduction), in addition to the contralateral medial rectus muscle for coordinated sideways movement of both eyes. CN VI charts the second longest intracranial course through the skull and originates from the abducens nucleus at the pons of the brainstem, through the subarachnoid space, dura mater, cavernous sinus and superior orbital fissure to reach the lateral rectus and contralateral medial rectus muscle. CN VI dysfunction can induce horizontal double vision and cause difficulty with sideways eye movements.⁵ 

Pathophysiology of cranial nerve involvement  

Granulomatous inflammation in the cavernous sinus

Granulomatous inflammation (an immune response where immune cells form clusters around infections) in the cavernous sinus has been associated with being a potential cause of THS. While the non-specific, chronic inflammation with unknown cause triggers the formation of granulomas, which are immune cells (e.g., fibroblasts, lymphocytes and plasma cells) clustered within a tight connective tissue,  compressing and exerting pressure around the cavernous sinus, which in turn irritates cranial nerves III, IV, VI that pass through the cavernous sinus. Hence, leading to the dysfunction and corresponding symptoms in the affected nerves.² 

Ischemia due to inflammation

Cavernous sinus inflammation can lead to ischemia (reduced blood flow).. While an excessive inflammatory response has been a primary cause of ischemic tissue damage, the compromised blood flow allows for less oxygen and nutrients to be transported towards CN III, IV, VI.⁶ Thereby, resulting in dysfunction to these cranial nerves, causing deficits such as facial weakness, numbness, various eye movement issues and visual disturbances. 

Clinical manifestations of cranial nerve involvement 

Cranial nerve III (oculomotor)

There are various signs and symptoms of CN III (oculomotor) dysfunction in THS. CN III is the major cranial nerve that controls eye movements, helping to open and rotate the eyes, as well as adjusting lens shape and pupil size. While showing up as a “down and out" eye position due to unopposing lateral rectus and superior oblique muscle, patients would typically experience: 

• Ptosis (drooping eyelid) caused by impaired eye elevation
• Trouble moving the eye of the affected side upward, downward or medially
• Diplopia (double vision)
• Strabismus (eye misalignment)
• Dilated (mydriasis) or unreactive pupils (in rare cases)

Cranial nerve IV (trochlear)

CN IV supplies the motor information to the superior oblique muscle for downward, inward, and outward eye motion., CN IV (trochlear) impairment in THS may cause:

• Visual disturbances and double vision, which can get worse when looking downward and inward (e.g., trouble reading or descending stairs)
• Eye misalignment
• Compensational head tilting, which might look like torticollis, is compensating for eye movement and visual challenges stemming from the affected superior oblique muscle

Cranial nerve VI (abducens)

Regarding the CN VI (abducens) involvement in THS, it is involved in the motor signalling for eye abduction and coordinating smooth side-to-side eye movement. When showing signs of dysfunction, CN VI may manifest as an eyeball staying in midline or slightly inward due to an unopposed medial rectus muscle. Individuals also experience:

• Difficulty or inability to move the eye laterally (left or right)
• Horizontal double vision worsens during lateral gaze
• Eye misalignment
• Eye strain or pain

Key features specific to tolosa-hunt syndrome 

Unilateral involvement of CN III, IV, and VI

The most distinctive feature of THS from other painful ophthalmoplegia (eye) and cranial neuropathies (nerve conditions) is its unilateral specificity that often affects only one side of the head. This is because the granulomatous inflamed cavernous sinus, superior orbital fissure or orbit that compresses and irritates CN III, IV, and VI are located only on one side of the skull. This results in apparent neurological impairment on the affected side, such as unilateral headache around the eye and paralysis of one or more oculomotor nerves on the same side. This unilateral nature is what largely differentiates it from other conditions, such as cavernous sinus thrombosis, orbital cellulitis, or cluster headaches.² 

Preceded or accompanied by severe orbital or periorbital pain 

Another hallmark of THS has been the severe orbital or periorbital pain that proceeds or occurs alongside CN III, IV, and VI dysfunctions, which clearly differentiate it from other painful conditions. While the intense, localised pain around the eye or within the orbit is often debilitating, it typically starts two weeks before or simultaneously with the oculomotor cranial nerve deficits. By which, this unique combination of unbearable headaches that extends to the eye or orbit of the same side, associated with cranial nerve dysfunction, is a unique clinical feature for identification and differentiation.²

Recurrence with rapid symptom improvement after corticosteroid use

The tendency for symptoms to recur intermittently with rapid improvement after the use of corticosteroids has been a notable, key diagnostic feature of THS. Severe orbital or periorbital pain or headache is associated with cranial nerve (III, IV, VI) dysfunctions or limited eye movements. Once corticosteroids are used, symptoms such as droopy eyelids, double vision or ophthalmoplegia (eye weakness or paralysis), particularly pain, are usually resolved within 1-3 days to a week. Alongside the intermittence, this significant symptomatic response to glucocorticoid or corticosteroid would  be highly suggestive of THS, which helps in confirming this diagnosis, differentiating it from other painful ophthalmoplegia and cranial neuropathies, benefiting from regular follow-up to assess cranial nerve recovery and prevent relapses.²

Absence of systemic infections or mass lesions

Given that THS is a diagnosis of exclusion, an additional notable feature that distinguishes THS from other conditions is the absence of infectious signs or mass lesions. Neuroimaging, ideally MRI scans with contrast, is necessary to confirm cavernous sinus, superior orbital fissure or orbit inflammation, while excluding other massive lesions such as stroke, tumours, or compressions. Furthermore, other tests such as CSF or comprehensive blood studies are also needed to rule out any neoplastic, vascular, or infectious causes of painful ophthalmoplegia. With the absence of infectious symptoms like fever, cough or swollen lymph nodes, Tolosa-Hunt Syndrome should only be confirmed after thorough medical investigations where intense orbital pain or painful eye weakness and paralysis are not better explained by other headache etiologies.² 

Prognosis and long-term outcomes 

While THS is still incurable currently, it is not life-threatening. Despite its potential recurrence, in approximately 40 to 50% of cases, the outlook is usually very satisfying with dramatic pain and symptom resolution after 1-3 days of steroid use. Cranial nerve dysfunctions will also improve gradually and fully recover within 2 to 8 weeks without any residual deficits, even without treatment.² 

Summary

Tolosa-Hunt Syndrome (THS) is a rare yet challenging neurological condition caused by idiopathic cavernous sinus or superior orbital fissure inflammation. It typically results in severe, one-sided headache that extends to the orbit, accompanied by dysfunction of oculomotor cranial nerves III, IV, and VI, impairing eye movement control and pupil dilation. While individuals usually experience droopy eyelid, diplopia, limited eye movement and painful ophthalmoplegia. General diagnoses upon a clinical exclusion, confirming cranial inflammation with distinctive features of unilateral involvement, distinctive severe orbital pain (headaches) predating or concurrent with cranial nerve impairments. Significant symptomatic relief is usually seen in response to corticosteroids. By clearly understanding how cranial nerves III, IV, and VI play a role in THS, accurate diagnosis and timely interventions are encouraged to ensure effective relapse prevention and treatment outcome optimisation for the population affected.